UK Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type) and By Application (Vitamins, Supplement, Nutrition)-Forecast to 2035

UK Softgel Capsule Market Overview

As per MRFR analysis, the UK Softgel Capsule Market Size was estimated at 468.75 (USD Million) in 2023. The UK Softgel Capsule Market Industry is expected to grow from 500(USD Million) in 2024 to 1,000 (USD Million) by 2035. The UK Softgel Capsule Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).

Key UK Softgel Capsule Market Trends Highlighted

The UK Softgel Capsule Market is experiencing significant trends that are being driven by the increasing demand for dietary supplements and the growing health consciousness of consumers. Softgel capsules have gained popularity as a convenient and easy-to-consume form of nutritional supplementation as a result of the transition to preventive healthcare. This trend is significantly influenced by the aging population and the increase in chronic diseases in the United Kingdom, which necessitates the development of efficient delivery systems for vitamins and other health products.

The UK market offers opportunities due to the increasing popularity of plant-based diets and veganism. In response to the growing number of environmentally conscious and health-conscious consumers, manufacturers have initiated the development of plant-based softgel capsules. This provides an opportunity for innovation and growth, particularly for companies that are prepared to invest in new technologies that can produce vegetarian and vegan softgels that can appeal to a broader customer base in the UK..

In recent years, consumers in the United Kingdom have also demonstrated a preference for transparency and quality in their health products, which has resulted in a trend toward the use of high-quality ingredients and plain labeling. Furthermore, the health sector's incorporation of technology has facilitated the selection of personalized supplements, allowing consumers to select softgel capsules that are specifically designed to meet their unique health needs.

The landscape is changing as the government supports innovation in the healthcare sector and promotes public health initiatives, providing potential growth opportunities for businesses in the UK softgel capsule market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

UK Softgel Capsule Market Drivers

Growing Demand for Nutraceuticals

The UK Softgel Capsule Market Industry is witnessing significant growth due to the increasing demand for nutraceuticals. This trend is driven by a rise in health awareness among consumers regarding preventive healthcare and the nutritional benefits of dietary supplements. According to a report from the Food Standards Agency, over 50% of the UK population now regularly consumes dietary supplements, marking a significant increase from previous years.Established companies like Herbalife and GNC are expanding their product lines to include softgel capsules, catering to this growing consumer base.

The demand for easy-to-swallow forms, particularly softgels, is also rising as they are perceived as more consumer-friendly compared to traditional tablets. This trend is expected to propel the growth of the UK Softgel Capsule Market as it aligns with consumer preferences towards convenient and effective health products.

Rising Prevalence of Chronic Diseases

The increasing occurrence of chronic diseases such as diabetes, cardiovascular diseases, and obesity is a significant driver for the UK Softgel Capsule Market Industry. Recent statistics from NHS England indicate that 26% of adults are living with at least one chronic condition. This growing patient population is leading to an increased need for effective medication delivery systems, such as softgel capsules, which are favored for their ability to mask unpleasant tastes and improve the bioavailability of drugs.

Pharmaceutical giants like GlaxoSmithKline and AstraZeneca are integrating softgel technology into their product offerings to enhance treatment efficacy, indicating a clear trend toward incorporating softgels into chronic disease management.

Advancements in Manufacturing Technology

Innovation in manufacturing processes is enhancing the production of softgel capsules, resulting in a positive impact on the UK Softgel Capsule Market Industry. The introduction of advanced encapsulation technologies and enhanced formulation strategies are enabling manufacturers to produce high-quality, stable, and effective soft gelatin capsules. The UK government has also been promoting initiatives to encourage advancements in pharmaceutical manufacturing through grants and support programs.With companies like Catalent and Lonza investing in state-of-the-art facilities and processes, the overall efficiency in softgel production is improving, thereby meeting increasing consumer demands effectively. As a result, this growing focus on efficiency and innovation in production technology is projected to drive sustained growth in the UK softgel market.

UK Softgel Capsule Market Segment Insights

Softgel Capsule Market Type Insights

The UK Softgel Capsule Market is categorized into various types, notably Gelatin Type and Non-Animal Type, representing a pivotal aspect of the market segmentation. Gelatin Type softgel capsules are widely utilized due to their excellent encapsulation qualities and bioavailability, making them a preferred choice for many pharmaceutical and dietary supplement formulations. This segment has historically garnered a significant portion of the market share, attributed to the reliability and effectiveness of gelatin as a natural product. On the other hand, the Non-Animal Type segment, which includes plant-based and vegetarian alternatives, is rapidly gaining traction, particularly in the UK, where there’s an increasing consumer demand for vegan and vegetarian options.

The rise of health consciousness among UK consumers has catalyzed the growth of this segment, presenting an opportunity for manufacturers to innovate in plant-derived materials while meeting dietary needs and ethical considerations. The growing concerns for animal welfare and the environment have also bolstered the demand for Non-Animal Type softgel capsules, reflecting a notable shift in consumer preferences.

Additionally, as awareness regarding dietary supplements increases, many manufacturers are adapting their product lines to include non-animal softgel options in response to this evolving landscape. Each type of softgel plays a crucial role in ensuring that consumers have access to effective and preferable dosage forms that align with their individual dietary needs and values. The UK government’s initiatives promoting healthier lifestyles and dietary supplements further enhance the prospects for both types, fostering a competitive environment in the industry.

As innovation continues, the segmentation within the UK Softgel Capsule Market will likely evolve, catering to diverse consumer preferences while addressing market growth dynamics and emerging trends. Each type, therefore, is not just a product offering but significant to overall market strategies and consumer satisfaction, affecting industry standards and projections alike.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Softgel Capsule Market Application Insights

The Application segment of the UK Softgel Capsule Market plays a crucial role in catering to diverse consumer needs, focusing primarily on Vitamins, Supplements, and Nutrition. This segment reflects a significant trend towards preventive healthcare and wellness, as consumers increasingly favor dietary supplements that promote overall health. With changing lifestyles and rising health awareness, the demand for vitamins has grown noticeably, driven by factors such as the aging population in the UK and a greater emphasis on fitness.

The supplement category is particularly prominent, addressing various health concerns and driving innovation in product development.Additionally, the nutrition aspect shapes the market, appealing to several demographics, including athletes and health-conscious individuals.

Given the UK's established pharmaceutical regulations, consumers often seek quality products that are effective and safe, further enhancing the significance of this Application segment. As health trends evolve, opportunities arise for manufacturers to introduce innovative softgel formulations that cater to specific health needs, ensuring sustained market growth and adaptation to consumer preferences.

UK Softgel Capsule Market Key Players and Competitive Insights

The UK Softgel Capsule Market has seen significant growth and competition driven by an increasing demand for dietary supplements and pharmaceuticals that offer enhanced bioavailability and convenience. Motivated by consumer preferences for easy-to-swallow formats, manufacturers are innovating to develop softgel products that cater to various health and wellness needs. The competition is characterized by a mix of established pharmaceutical companies and specialized nutraceutical firms, all vying for market share through product differentiation, branding, and strategic partnerships. In this landscape, companies seek to leverage their research and development capabilities to introduce new formulations and expand their product lines to meet diverse consumer demands while adhering to regulatory standards.

Forte Pharma has established a strong foothold in the UK Softgel Capsule Market by focusing on wellness products that align with consumer trends toward health enhancement and natural solutions. The brand is recognized for its commitment to developing high-quality, effective dietary supplements, particularly those aimed at solving specific health issues such as weight management, energy boosting, and skin health. Forte Pharma's strengths in the UK market can be attributed to its well-defined product portfolio, strong brand loyalty among consumers, and dedicated distribution channels that facilitate accessibility.

The company's marketing strategies emphasize transparency and efficacy, helping to build trust and a solid reputation in a competitive landscape where consumers are increasingly discerning about the supplements they choose.Lonza is a prominent player in the UK Softgel Capsule Market, leveraging its extensive expertise in the life sciences sector to deliver high-quality softgel solutions for dietary supplements and pharmaceuticals. Known for its robust manufacturing capabilities, Lonza's portfolio includes a range of softgel formulations that cater to various applications, ensuring compliance with stringent regulatory requirements. The company is committed to innovation, investing in research and development to enhance its product offerings continuously.

Lonza's strength lies in its ability to customize formulations according to specific customer needs, providing tailored solutions that support its clients' market strategies. The presence of Lonza in the UK market is further reinforced by strategic mergers and partnerships, allowing for greater operational efficiencies and access to a wider customer base. Their dedication to sustainability and quality assurance also distinguishes them in the marketplace, enabling them to meet the rising consumer expectations for clean-label products.

Key Companies in the UK Softgel Capsule Market Include

• Forte Pharma


• Lonza


• Eligo Bioscience


• BASF


• Aesculap


• Aenova


• Integrity Nutraceuticals


• Catalent


• Qualipac


• Rottapharm Madaus


• Capsugel


• Amgen


• Haleon


• Stada Arzneimittel


• Pharmalink

UK Softgel Capsule Market Industry Developments

The UK Softgel Capsule Market has witnessed significant developments recently, with companies like Lonza and Capsugel actively enhancing their manufacturing capabilities. In March 2023, Aenova expanded its operations with a new facility aimed at improving production efficiency and meeting rising consumer demand. The market is also experiencing growth in valuation, driven by the increasing popularity of dietary supplements, with Forte Pharma and Integrity Nutraceuticals leading in innovation.

Mergers and acquisitions have played a crucial role. Notably, in June 2023, Amgen announced a strategic acquisition that aims to strengthen its market position in the biopharmaceutical sector, while Stada Arzneimittel expanded its product lineup. The DNA-based therapies sector is also tangentially linked, with Eligo Bioscience exploring partnerships to enhance delivery systems in softgel formulations.

Additionally, ongoing research and development advances are set to influence growth as companies adapt to consumer trends and regulatory changes, reflecting an increasing emphasis on sustainable practices within the industry. Major happenings over the past 2-3 years include the push for transparency in ingredient sourcing and the regulatory scrutiny of softgel formulations, with the UK government advocating for stricter quality standards to ensure consumer safety.

UK Softgel Capsule Market Segmentation Insights

Softgel Capsule Market Type Outlook

• Gelatin Type


• Non-Animal Type

Softgel Capsule Market Application Outlook

• Vitamins


• Supplement


• Nutrition

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	468.75(USD Million)
MARKET SIZE 2024	500.0(USD Million)
MARKET SIZE 2035	1000.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.504% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Forte Pharma, Lonza, Eligo Bioscience, BASF, Aesculap, Aenova, Integrity Nutraceuticals, Catalent, Qualipac, Rottapharm Madaus, Capsugel, Amgen, Haleon, Stada Arzneimittel, Pharmalink
SEGMENTS COVERED	Type, Application
KEY MARKET OPPORTUNITIES	Rising demand for nutraceuticals, Increasing preference for convenience products, Growth in aging population, Expanding herbal supplement market, Innovations in capsule technology
KEY MARKET DYNAMICS	rising health consciousness, increasing demand for dietary supplements, technological advancements in manufacturing, growing prevalence of chronic diseases, preference for convenient dosage forms
COUNTRIES COVERED	UK